Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/10/2026 | 2,272 | 0.0% | 34,228 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 1,214 | 0.0% | 35,210 | 9/30/2025 |
| 2025 Q2 | 8/8/2025 | 510 | 0.0% | 32,265 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 384 | 0.0% | 30,176 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 516 | 0.0% | 27,455 | 12/31/2024 |
| 2024 Q3 | 11/7/2024 | 531 | 0.0% | 27,403 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 715 | 0.0% | 27,528 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 784 | 0.0% | 27,407 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 724 | 0.0% | 23,653 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 583 | 0.0% | 21,707 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 1,843 | 0.0% | 51,674 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 1,239 | 0.0% | 48,783 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 1,931 | 0.0% | 47,617 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 1,387 | 0.0% | 41,967 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 1,474 | 0.0% | 41,859 | 6/30/2022 |
| 2022 Q1 | 5/12/2022 | 1,778 | 0.0% | 38,650 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 2,292 | 0.0% | 34,567 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 2,150 | 0.0% | 34,444 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 2,872 | 0.0% | 34,675 | 6/30/2021 |
| 2021 Q1 | 5/12/2021 | 2,296 | 0.0% | 34,626 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 2,633 | 0.0% | 34,314 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 1,412 | 0.0% | 32,785 | 9/30/2020 |
| 2020 Q2 | 8/11/2020 | 930 | 0.0% | 21,531 | 6/30/2020 |
| 2020 Q1 | 5/14/2020 | 678 | 0.0% | 23,551 | 3/31/2020 |
| 2019 Q4 | 2/11/2020 | 1,120 | 0.0% | 17,657 | 12/31/2019 |